EASL Clinical Practice Guidelines: Drug-induced liver injury

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280

The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety

Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903

The influence of drug-like concepts on decision-making in medicinal chemistry

Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx225 · Cited by 2,367

Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127

Acetaminophen‐induced acute liver failure

Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., REISCH, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,913

Simplified criteria for the diagnosis of autoimmune hepatitis

Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901

Drug-induced liver injury in pregnancy

Lao, T. T.-H. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.03.005 · Cited by 27

Effectiveness of Integrative Chinese–Western Medicine for Chronic Kidney Disease and Diabetes: A Retrospective Cohort Study

Chan, K. W., Chow, T. Y., Yu, K. Y., Feng, Y., Lao, L., Bian, Z., Wong, V. T., & Tang, S. C.-W. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2250015x · Cited by 26

Glucocorticoid Treatment Strategies in Liver Failure

Ye, C., Li, W., Li, L., & Zhang, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.846091 · Cited by 26

Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug‐induced liver injury: A multicenter, randomized, phase II trial

Tang, J., Gu, J., Chu, N., Chen, Y., Wang, Y., Xue, D., Xie, Q., Li, L., Mei, Z., Wang, X., et al. (2022) · Liver International · doi:10.1111/liv.15290 · Cited by 25

Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms

Weng, S., Hu, D., Chen, J., Yang, Y., & Peng, D. (2023) · Diagnostics · doi:10.3390/diagnostics13061168 · Cited by 26

Diagnostic Performance and Safety of a Novel Ferumoxytol-Enhanced Coronary Magnetic Resonance Angiography

Dong, Z., Si, G., Zhu, X., Li, C., Hua, R., Teng, J., Zhang, W., Xu, L., Qian, W., Liu, B., et al. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.015404 · Cited by 26

An entropy weight method to integrate big omics and mechanistically evaluate DILI

Jin, Y., Shou, Y., Lei, Q., Du, C., Xu, L., Chen, N., Ma, W., Zhu, X., Zhou, S., Zheng, Y., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000628 · Cited by 26

A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale

Shi, X., Lao, D., Xu, Q., Li, X., & Lv, Q. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07258-w · Cited by 26

Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed

Rigopoulou, E. I., Gatselis, N., Arvaniti, P., Koukoulis, G. Κ., & Dalekos, G. Ν. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.12.024 · Cited by 25

Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review

Atallah, E., Freixo, C., Álvarez‐Álvarez, I., Cubero, F. J., Gerbes, A. L., Kullak-Ublick, G. A., & Aithal, G. P. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1999410 · Cited by 25

Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis

Fu, L., Qian, Y., Shang, Z., Sun, X., Kong, X., & Gao, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.972518 · Cited by 25

The use of Andrographis paniculata and its effects on liver biochemistry of patients with gastrointestinal problems in Thailand during the COVID-19 pandemic: a cross sectional study

Kaewdech, A., Nawalerspanya, S., Assawasuwannakit, S., Chamroonkul, N., Jandee, S., & Sripongpun, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-23189-7 · Cited by 25

ONOO--triggered fluorescence H2S donor for mitigating drug-induced liver injury

Liu, J., Zhao, M., Zhao, F., Song, X., & Ye, Y. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.133131 · Cited by 25

An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation

Lee, S. K., Choi, J. Y., Jung, E. S., Kwon, J. H., Jang, J. W., Bae, S. H., & Yoon, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055002 · Cited by 25

Anticancer drugs are the first cause of drug‐induced liver injury in a reference hospital

Pocurull, A., Moreta, M. J., Heitman, D. W., Olivas, I., Collazos, C., Canga, E., Sáez‐Peñataro, J., Andrade, R. J., Lucena, M. I., Mariñó, Z., et al. (2023) · Liver International · doi:10.1111/liv.15821 · Cited by 25

Risk Factors for Hepatotoxicity Due to Paracetamol Overdose in Adults

Popiołek, I., Hydzik, P., Jagielski, P., Zrodlowska, M., Mystek, K., & Porębski, G. (2021) · Medicina · doi:10.3390/medicina57080752 · Cited by 24

Pancreatic damage in COVID‐19: Why? How?

Bacaksız, F., Ebik, B., Ekin, N., & Kılıç, J. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14692 · Cited by 24

Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy

Gabrielli, M., Franza, L., Esperide, A., Irene, G., Gasbarrini, A., Franceschi, F., & 2019, O. B. O. G. A. C. (2022) · Vaccines · doi:10.3390/vaccines10020192 · Cited by 24

A review of herb-induced liver injury in mainland china

Yang, Y., Ge, F., Tang, J., Qin, S., Zeng, R., Yao, M., Xiao, X.-H., Bai, Z., & Tang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.813073 · Cited by 24

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

Segovia‐Zafra, A., Paz, M. V., Serras, A. S., Matilla‐Cabello, G., Bodoque-García, A., Zeo-Sánchez, D. E. D., Niu, H., Álvarez‐Álvarez, I., Sanz‐Villanueva, L., Godec, S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.026 · Cited by 24

Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review

Niu, H., Atallah, E., Álvarez‐Álvarez, I., Medina‐Cáliz, I., Aithal, G. P., Arıkan, Ç., Andrade, R. J., & Lucena, M. I. (2022) · Drug Safety · doi:10.1007/s40264-022-01224-w · Cited by 24

Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases

Wu, M., Li, K., Wu, J., Ding, X., Ma, X., Wang, W., & Xiao, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2024.107571 · Cited by 23

Selenium, silver, and gold nanoparticles: Emerging strategies for hepatic oxidative stress and inflammation reduction

Karunakar, K. K., Cheriyan, B. V., Babu, D., Devan, P., Jayaprakash, N., Suresh Kannan, M., Yabase, L., & Kataria, K. R. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100085 · Cited by 23

Metabolomics analysis of plasma reveals voriconazole-induced hepatotoxicity is associated with oxidative stress

Wu, S.-L., Cheng, C., Wang, C., Lin, S., & Kuo, C. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115157 · Cited by 23

Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study

Druschky, K., Toto, S., Bleich, S., Baumgärtner, J., Engel, R. R., Grohmann, R., Maier, H. B., Neyazi, A., Rudolph, Y. J., Rüther, E., et al. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1819565 · Cited by 23

A study to evaluate the hepatoprotective effect of N- acetylcysteine on anti tuberculosis drug induced hepatotoxicity and quality of life

Sukumaran, D., Usharani, P., Paramjyothi, G. K., Subbalaxmi, M. V. S., Sireesha, K., & Ali, M. A. (2022) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2022.05.012 · Cited by 23

Uncovering the flip side of immune checkpoint inhibitors: a comprehensive review of immune-related adverse events and predictive biomarkers

Miao, Y., Quan, W., Tang, X., Shi, W., Li, Q., Li, R. J., Wang, J., Gan, J., Dong, X., Liang, H., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.89376 · Cited by 23

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review

Ruli, T. M., Pollack, E. D., Lodh, A., Evers, C. D., Price, C. A., & Shoreibah, M. (2024) · Cancers · doi:10.3390/cancers16112042 · Cited by 23

Drug-Drug Combinations Can Enhance Toxicity as Shown by Monocyte-Derived Hepatocyte-like Cells From Patients With Idiosyncratic Drug-Induced Liver Injury

Benesic, A., Jalal, K., & Gerbes, A. L. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz156 · Cited by 23

Movement Disorders and Liver Disease

Mulroy, E., Baschieri, F., Magrinelli, F., Latorre, A., Cortelli, P., & Bhatia, K. P. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13238 · Cited by 23

Zanubrutinib-induced liver injury: a case report and literature review

Atallah, E., Wijayasiri, P., Cianci, N., Abdullah, K., Mukherjee, A., & Aithal, G. P. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01825-2 · Cited by 23

Liver injury associated with drug intake during pregnancy

Kamath, P., Kamath, A., & Ullal, S. D. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i7.747 · Cited by 23

CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatment

Meunier, L., Martin, E. D., Delire, B., Jacot, W., Guiu, S., Zahhaf, A., Larrey, D. G., & Horsmans, Y. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101098 · Cited by 22

Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury

Liu, N., Liu, J., Zheng, B., Zeng, X., Ye, Z., Huang, X., Liu, W., Liu, Y., Fang, Q., Chen, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114400 · Cited by 22

Metabolic Disorders Are Associated With Drug-Induced Liver Injury During Antituberculosis Treatment: A Multicenter Prospective Observational Cohort Study in Korea

Lim, J., Kim, J. S., Kim, H. W., Kim, Y. H., Jung, S. S., Kim, J. W., Oh, J. Y., Lee, H., Kim, S. K., Kim, S., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad422 · Cited by 22

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury

Zhang, Y., Fan, Y., Hu, H., Zhang, X., Wang, Z., Wu, Z., Wang, L., Yu, X., Song, X., Peng, X. H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43439-0 · Cited by 23

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU

Riveiro‐Barciela, M., Carballal, S., Díaz‐González, Á., Mañosa, M., Gallego-Plazas, J., Cubiella, J., Jiménez‐Fonseca, P., Varela, M., Menchen, L. A., Sangro, B., et al. (2024) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2023.10.009 · Cited by 22

ZBP1 promotes hepatocyte pyroptosis in acute liver injury by regulating the PGAM5/ROS pathway

Yan, S., Yu, L., Chen, Z., Xie, D., Huang, Z., & Ouyang, S. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101475 · Cited by 21

Drug‐induced liver injury related to gene therapy: A new challenge to be managed

Larrey, D. G., Delire, B., Meunier, L., Zahhaf, A., Martin, E. D., & Horsmans, Y. (2024) · Liver International · doi:10.1111/liv.16065 · Cited by 21

Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease

Estilo, A., Tracy, L. A., Matthews, C., Riggen, M., Stemhagen, A., Wilt, T. J., Krakovich, A., Jones-Burton, C., George, V., McQuade, R. D., et al. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac076 · Cited by 21

Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701

Teixeira, M., Macedo, S. S., Batista, T., Martins, S. C., Correia, A., & Matos, L. C. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.1.12 · Cited by 21

A case of self-limited drug induced liver injury under treatment with elexacaftor/tezacaftor/ivacaftor: When it is worth taking the risk

Stylemans, D., François, S., Vincken, S., Verbanck, S. A. B., & Vanderhelst, E. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.05.017 · Cited by 21

Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan

Huang, Y., Wu, C., Chang, T., Peng, C., Lo, G., Hsu, C., Hu, C., & Huang, Y. (2021) · Liver International · doi:10.1111/liv.14990 · Cited by 20

Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics

Zhai, X., Zou, Z., Wang, J.-B., & Xiao, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.738577 · Cited by 21

Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature

Študentová, H., Volakova, J., Spisarová, M., Zemánková, A., Aiglová, K., Szotkowski, T., & Melichar, B. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02121-3 · Cited by 21

Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People

Lunghi, C., Trevisan, C., Fusaroli, M., Giunchi, V., Raschi, E., Sangiorgi, E., Domenicali, M., Volpato, S., Ponti, F. D., & Poluzzi, E. (2022) · Pharmaceuticals · doi:10.3390/ph15080977 · Cited by 21

Safety and Disease Monitoring Biomarkers in Duchenne Muscular Dystrophy: Results From A Phase Ii Trial

Wagner, K. R., Guglieri, M., Ramaiah, S. K., Charnas, L. R., Marraffino, S., Binks, M. H., Vaidya, V. S., Palmer, J. P., Goldstein, R., & Muntoni, F. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2021-0222 · Cited by 20

Fraxinellone Induces Hepatotoxicity in Zebrafish through Oxidative Stress and the Transporters Pathway

Wang, S., Bao, J., Bao, J., Li, J., Tian, M., Qiu, C., Pang, F., Li, X., Yang, J., Hu, Y., et al. (2022) · Molecules · doi:10.3390/molecules27092647 · Cited by 20

Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal

Raschi, E., Fusaroli, M., Gatti, M., Caraceni, P., Poluzzi, E., & Ponti, F. D. (2022) · Pharmaceuticals · doi:10.3390/ph15050645 · Cited by 20

Ribociclib-induced liver injury: a case report

Schaeffer, S., Lutz, C., Dobbie, M., Terracciano, L., Matter, M. S., Vosbeck, J., Heim, M. H., & Bernsmeier, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1256783 · Cited by 20

Croton's therapeutic promise: A review of its phytochemistry and critical computational ADME/Tox analysis

Obende, S. O., Ochieng, C. O., Shikanga, E. A., Cruz, J. N., Santos, C. B. R., & Kimani, N. M. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.06.031 · Cited by 20

Time to use the right classification to predict the severity of checkpoint inhibitor‐induced liver injury, as assessed for causality using the updated RUCAM

Hountondji, L., Faure, S., Palassin, P., Viel, P. W. D., Dupuy, M., Larrey, D. G., Lamoureux, A., Coustal, C., Pureur, D., Lesage, C., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18276 · Cited by 20

Aloperine Ameliorates Acetaminophen‐Induced Acute Liver Injury through HMGB1/TLR4/NF‐ κ B and NLRP3/Inflammasome Pathway

Chen, H., Wang, S., Chen, Q., Yu, W., Nie, H., Liu, L., Zheng, B., & Gong, Q. (2024) · Mediators of Inflammation · doi:10.1155/2024/3938136 · Cited by 20

Advanced liver-on-chip model mimicking hepatic lobule with continuous microvascular network via high-definition laser patterning

Watanabe, M., Salvadori, A., Marković, M., Sudo, R., & Ovsianikov, A. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101643 · Cited by 20

Drug‐Induced Liver Injury After Liver Transplantation

Pérez, M. J., González‐Grande, R., García‐Cortés, M., & Andrade, R. J. (2020) · Liver Transplantation · doi:10.1002/lt.25804 · Cited by 20

Drug‐induced liver injury at a tertiary care centre in Germany: Model for end‐stage liver disease is the best predictor of outcome

Reike‐Kunze, M., Zenouzi, R., Hartel, J., Krech, T., Weidemann, S. A., Sterneck, M. R., Weiler‐Normann, C., Lohse, A. W., Schramm, C., & Sebode, M. (2021) · Liver International · doi:10.1111/liv.14985 · Cited by 20

The therapeutic potential of exosomes derived from different cell sources in liver diseases

Pan, Y., Tan, W., Yang, M., Li, J., & Geller, D. A. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00054.2021 · Cited by 20

Selected Liver Markers in Predicting the Severity of Organophosphate and Carbamate Poisoning

Senarathne, R., Hettiaratchi, U. P. K., Athiththan, L. V., Peiris, H., Sarathchandra, C., Senanayake, H., Weerawansa, P., & Siribaddana, S. (2022) · Journal of Environmental and Public Health · doi:10.1155/2022/7826396 · Cited by 20

Therapeutic potential of plant-derived natural products against drug-induced liver injury

Chen, Y., Mei, Y., Hou, L., & Li, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1652860 · Cited by 19

Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations

Caballero-Mateos, A. M., Brunet, E., & Gros, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14227984 · Cited by 19

Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Lee, J. Y., Ang, A. S. Y., Ali, N. M., Ang, L. M., & Omar, A. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00370-3 · Cited by 19

Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients

Purde, M.-T., Niederer, R., Wagner, N. B., Diem, S., Berner, F., Ali, O. H., Hillmann, D., Bergamin, I., Joerger, M., Risch, M., et al. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03870-6 · Cited by 19

Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study

Shimose, S., Iwamoto, H., Tanaka, M., Niizeki, T., Kajiwara, M., Itano, S., Moriyama, E., Shirono, T., Noda, Y., Kamachi, N., et al. (2022) · Cancers · doi:10.3390/cancers14174284 · Cited by 19

175 Years of Bilirubin Testing: Ready for Point‐of‐Care?

Guirguis, N., Bertrand, A., Rose, C. F., & Matoori, S. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203380 · Cited by 19

Defining characteristics and long‐term prognosis of drug‐induced autoimmune‐like hepatitis: A retrospective cohort study

Chung, Y., Morrison, M., Zen, Y., & Heneghan, M. A. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12499 · Cited by 19

Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity

Khalil, S. M., MacKenzie, K. R., Maletić‐Savatić, M., & Li, F. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2313967 · Cited by 19

Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Yamamoto, T., Ito, T., Hase, T., Ishigami, M., Mizuno, K., Yamamoto, K., Imai, N., Ishizu, Y., Honda, T., Shibata, H., et al. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1994586 · Cited by 19

Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders

Mazza, S., Soro, S., Verga, M. C., Elvo, B., Ferretti, F., Cereatti, F., Drago, A., & Grassia, R. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i12.1828 · Cited by 19

Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002–2022

Yu, S., Li, J., He, T., Zheng, H., Wang, S., Sun, Y., Wang, L., Jing, J., & Wang, R. (2024) · Hepatology International · doi:10.1007/s12072-024-10679-1 · Cited by 18

Safety of Herbal Medicines: Clinical and Pharmacological Aspects

Демидова, О. А., Arkhipov, V. V., Zhuravleva, M. V., Alexandrova, T. V., & Alexandrov, A. A. (2020) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2020-8-4-165-177 · Cited by 18

Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM

Qin, F.-L., Sang, G.-Y., Zou, X., & Cheng, D.-H. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/5914593 · Cited by 18

Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations

Gillessen, A., Angelico, F., Chen, J., Lu, L., Lucena, M. I., Fu, Q., Xie, Q., Andrade, R. J., Xie, W., Xu, X., et al. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.05.006 · Cited by 18

Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction

Mekonnen, A. T., & Wondmeneh, T. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-17618-w · Cited by 18

Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients

Urzua, A. M., Pizarro, C., Gajardo, A. I. J., Poniachik, R., Pavez, C., Cattaneo, M., Brahm, J., Carreño, L. E., & Poníachik, J. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/6470847 · Cited by 18

Endoplasmic reticulum stress regulates autophagic response that is involved in Saikosaponin a-induced liver cell damage

Wang, Y., Ma, R., Zou, B., Li, J., Yao, Y., & Li, J. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105534 · Cited by 18

Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury

Niu, H., Álvarez‐Álvarez, I., & Chen, M. (2025) · Liver International · doi:10.1111/liv.70038 · Cited by 18

Recent advances in understanding the hepatotoxicity associated with protein kinase inhibitors

Shi, Q., Yang, X., Ren, L., & Mattes, W. B. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1727886 · Cited by 18

High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus

Chen, M., Wu, C., Chen, M., Tsai, C., Lee, F., & Huang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179116 · Cited by 18

Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases

Burra, P., Cammà, C., Invernizzi, P., Marra, F., & Pompili, M. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.101900 · Cited by 17

Safety of treating acute liver injury and failure

García‐Cortés, M., Ortega‐Alonso, A., & Andrade, R. J. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1955854 · Cited by 17

Drug‐induced Liver Injury in Pediatrics

Urrea, F. M., & Montijo-Barrios, É. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003535 · Cited by 17

Immunotherapy for Cancer: Common Gastrointestinal, Liver, and Pancreatic Side Effects and Their Management

Sedaño, R., Cabrera, D., Jiménez, A., Ma, C., Jairath, V., Arrese, M. A., & Arab, J. P. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001983 · Cited by 18

Ethyl gallate concurrent administration protects against acetaminophen‐induced acute liver injury in mice: An in vivo and in silico approach

Ezhilarasan, D., Harini, K. S., Karthick, M., & Selvaraj, C. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14369 · Cited by 17

Single-cell omics in tracing cellular heterogeneity of drug-induced liver injury: Technological landscape and prospective application

Mao, X., Xu, M., Yan, X., Chen, L., Lin, N., & Zhang, Y. (2024) · hLife · doi:10.1016/j.hlife.2024.01.004 · Cited by 17

The ABC of Immune-Mediated Hepatitis during Immunotherapy in Patients with Cancer: From Pathogenesis to Multidisciplinary Management

Lasagna, A., & Sacchi, P. (2024) · Cancers · doi:10.3390/cancers16040795 · Cited by 17

Ibuprofen induced Stevens-Johnson syndrome and liver injury in children: a case report

Gui, M., Ni, M., Yin, X., Zhang, T., & Li, Z. (2021) · Translational Pediatrics · doi:10.21037/tp-21-8 · Cited by 17

New Perspectives to Improve Mesenchymal Stem Cell Therapies for Drug-Induced Liver Injury

Ezquer, F. E., Huang, Y.-L., & Ezquer, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052669 · Cited by 17

LIVER INJURY INDUCED BY HERBAL AND DIETARY SUPPLEMENTS: A POOLED ANALYSIS OF CASE REPORTS

de Assis, M. H., Alves, B. C., Luft, V. C., & Dall’Alba, V. (2022) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202204000-84 · Cited by 17

Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature

Mohamed, W. T., Jahagirdar, V., Fatima, I., Ahmed, M., Jaber, F. S., Wang, K., Hassan, A. A., Ewing, E., Clarkston, W., & Likhitsup, A. (2023) · Cureus · doi:10.7759/cureus.35094 · Cited by 17

Pathophysiological role of BACH transcription factors in digestive system diseases

Song, Q., Mao, X., Jing, M., Fu, Y., & Yan, W. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1121353 · Cited by 17

An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children

Sandritter, T. L., Goldman, J. L., Habiger, C. J., Daniel, J. F., Lowry, J. A., & Fischer, R. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-54075-4 · Cited by 16

Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling

Su, W., Song, S., Liu, J., Yu, H., Feng, B., Wu, Y., Guo, F., & Yu, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1342947 · Cited by 16

Beyond Antibiotics: What the Future Holds

Benyamini, P. (2024) · Antibiotics · doi:10.3390/antibiotics13100919 · Cited by 16

Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach

Sanabria‐Cabrera, J., Medina‐Cáliz, I., Stankevičiūtė, S., Rodríguez-Nicolás, A., Almarza-Torres, M., Lucena, M. I., & Andrade, R. J. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191107161912 · Cited by 16

Mechanisms of liver damage in COVID-19

Витальевна, П. Т., Nv, O., Суранова, Т. Г., & Bonkalo, T. I. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-19-39-46 · Cited by 16

Inhibition of Drug‐Induced Liver Injury in Mice Using a Positively Charged Peptide That Binds DNA

Marques, P. E., Vandendriessche, S., de Oliveira, T. H. C., Crijns, H., Lopes, M. E., Blanter, M., Schuermans, S., Yu, K., Poosti, F., Vanheule, V., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1759 · Cited by 16

Hepatitis autoinmune: retos y novedades

Olivas, I., Rodríguez‐Tajes, S., & Londoño, M. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.04.004 · Cited by 16

Defining appropriate utilization of AST testing

Mohammed‐Ali, Z., Brinc, D., Kulasingam, V., & Selvaratnam, R. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.02.006 · Cited by 16

Methods for causality assessment of idiosyncratic drug‐induced liver injury

García‐Cortés, M., Matilla‐Cabello, G., & Lucena, M. I. (2025) · Liver International · doi:10.1111/liv.16083 · Cited by 15

Progress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice

von Samson‐Himmelstjerna, F. A., Kolbrink, B., Riebeling, T., Kunzendorf, U., & Krautwald, S. (2022) · Cells · doi:10.3390/cells11142134 · Cited by 15

[EASL clinical practice guidelines recommendations for drug-induced liver injury in 2019].

Liu, L., Zhao, X., & Jia, J. (2019) · PubMed · doi:10.3760/cma.j.issn.1007-3418.2019.06.006 · Cited by 7

Advances in the management of idiosyncratic drug-induced liver injury

Memon, A., Yeboah‐Korang, A., & Fontana, R. J. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000052 · Cited by 3

Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications

Watkins, P. B. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.02.004 · Cited by 10

ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury

Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860

Idiosyncratic drug‐induced liver injury: A short review

Yamashita, Y., Imai, K., Mima, K., Nakagawa, S., Hashimoto, D., Chikamoto, A., & Baba, H. A. (2017) · Hepatology Communications · doi:10.1002/hep4.1064 · Cited by 33